Suchergebnisse - "Feigin, Andrew"

PubPharm (7)

1

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD) : a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

enthalten in: The Lancet. Neurology | 2024

von Reilmann, R. | Anderson, K. | Feigin, A. | +61

2

Pepinemab antibody blockade of SEMA4D in early Huntington's disease : a randomized, placebo-controlled, phase 2 trial

enthalten in: Nature medicine | 2022

von Feigin, A. | Evans, E. | Fisher, T. | +49

ErratumIn: Nat Med. 2022 Oct 4;:. - PMID 36195687

3

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD) : a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

enthalten in: The Lancet. Neurology | 2019

von Reilmann, R. | McGarry, A. | Grachev, I. | +114

CommentIn: Lancet Neurol. 2019 Feb;18(2):131-133. - PMID 30563777

4

Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity

enthalten in: Science translational medicine | 2018

von Niethammer, M. | Tang, C. | Vo, A. | +9

CommentIn: Nat Rev Neurol. 2019 Jan;15(1):2. - PMID 30542071

5

Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease

enthalten in: JCI insight | 2017

von Niethammer, M. | Tang, C. | LeWitt, P. | +19

6

A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia

enthalten in: Movement disorders : official journal of the Movement Disorder Society | 2016

von Trenkwalder, C. | Berg, D. | Rascol, O. | +30

7

A pilot clinical trial of creatine and minocycline in early Parkinson disease : 18-month results

enthalten in: Clinical neuropharmacology | 2008

von NINDS NET-PD Investigators | Racette, B. | Deppen, P. | +93

1
[1]